ProShares Ultra Nasdaq Biotechnology BIB
Morningstar’s Analysis BIB
There is no Morningstar’s Analysis data available.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 47.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Bills 0% | 11.98 | 9.9 Mil | Government |
Cte ? Proshares Trust M | 10.18 | 8.4 Mil | — |
Gilead Sciences Inc | 6.27 | 5.2 Mil | Healthcare |
Amgen Inc | 5.60 | 4.6 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 5.38 | 4.5 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 5.04 | 4.2 Mil | Healthcare |
AstraZeneca PLC ADR | 3.24 | 2.7 Mil | Healthcare |
Nasdaq Biotechnology Index Swap | 3.15 | 2.6 Mil | — |
Alnylam Pharmaceuticals Inc | 2.47 | 2.0 Mil | Healthcare |
Nasdaq Bio Index Swap Bnp | 2.44 | 2.0 Mil | — |